Riskpilot← Back to searchSign inGet full accessLIFECORE BIOLOGY ApS
APSActiveCVR 35241981Jelshøjvænget 9Other human health activities n.e.c. · NACE 8699Est. 20131 employees
Revenue 2025
DKK 49K
+867% vs 2024
EBITDA margin
100.0%
+867% vs 2024
Equity ratio
8.1%
Financial strength
Net profit 2025
DKK -192K
-24737% vs 2024
| Revenue | DKK 49K | +867% |
| EBITDA | DKK 49K | +867% |
| Net profit | DKK -192K | -24737% |
| Total assets | DKK 986K | +214% |
| Equity | DKK 80K | -67% |
| Employees | 1 | — |
Legal name
LIFECORE BIOLOGY ApS
CVR number
35241981
Legal form
Anpartsselskab
NACE code
8699 · Other human health activities n.e.c.
Founded
14. maj 2013
Share capital
DKK 80.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-05-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør.
Company purpose
Selskabets formål er at yde sundhedsrådgivning til virksomheder og privatpersoner samt anden i forbindelse hermed stående virksomhed.
Address
Jelshøjvænget 9
Phone
+4528123461
Email
info@torehartelius.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -70 | -76 | 78 | 27 | 55 | -21 | -11 | -11 | -14 | 22 | 5 | 49 |
| Staff expenses | -0 | -7 | -18 | -0 | -7 | -0 | -0 | -242 | -4 | -0 | -0 | -0 |
| EBITDA | -70 | -83 | 60 | 27 | 48 | -21 | -11 | -252 | -18 | 22 | 5 | 49 |
| Depreciation & amort. | -28 | -41 | -45 | -45 | -45 | -37 | -28 | -0 | -0 | -0 | -0 | -83 |
| EBIT | -98 | -125 | 15 | -18 | 2 | -58 | -39 | -252 | -18 | 22 | 5 | -34 |
| Net financials | -8 | -13 | 2 | 2 | -0 | -1 | -1 | -5 | -13 | -14 | -4 | -47 |
| Profit before tax | -105 | -81 | 17 | -17 | 2 | -59 | -39 | -257 | -32 | 8 | 1 | -81 |
| Tax | -25 | 28 | 4 | -4 | 19 | -13 | -8 | -56 | -5 | -10 | 0 | 111 |
| Net profit | -81 | -109 | 13 | -13 | -17 | -46 | -30 | -201 | -27 | 17 | 1 | -192 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 343 | 412 | 305 | 265 | 267 | 200 | 164 | 217 | 138 | 243 | 314 | 986 |
| Equity | -1 | 242 | 255 | 242 | 225 | 179 | 149 | -52 | -28 | 238 | 239 | 80 |
| Long-term debt | 190 | 150 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 153 | 20 | 51 | 23 | 42 | 21 | 15 | 269 | 166 | 5 | 75 | 906 |
| Total debt | 343 | 171 | 51 | 23 | 42 | 21 | 15 | 269 | 166 | 5 | 75 | 906 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20142025
Equity ratio
8.1%
This company
38.2%
Market median
-79% vs market
20142025
Return on equity
-240.2%
This company
18.4%
Market median
-1405% vs market
20142025
Net profit margin
-390.2%
This company
8.1%
Market median
-4917% vs market
20142025
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20142025
Debt / equity
11.33×
This company
0.62×
Market median
-1727% vs market
20142025
- Annual report 2025Filed via CVR / Virk · Period 2024-06-01 – 2025-05-31
- Annual report 2024Filed via CVR / Virk · Period 2023-06-01 – 2024-05-31
- Annual report 2023Filed via CVR / Virk · Period 2022-06-01 – 2023-05-31
- Annual report 2022Filed via CVR / Virk · Period 2021-06-01 – 2022-05-31
- Annual report 2021Filed via CVR / Virk · Period 2020-06-01 – 2021-05-31
- Annual report 2020Filed via CVR / Virk · Period 2019-06-01 – 2020-05-31
- Annual report 2019Filed via CVR / Virk · Period 2018-06-01 – 2019-05-31
- Annual report 2018Filed via CVR / Virk · Period 2017-06-01 – 2018-05-31
- Annual report 2017Filed via CVR / Virk · Period 2016-06-01 – 2017-05-31
- Annual report 2016Filed via CVR / Virk · Period 2015-06-01 – 2016-05-31
- Annual report 2015Filed via CVR / Virk · Period 2014-06-01 – 2015-05-31
- Annual report 2014Filed via CVR / Virk · Period 2013-05-14 – 2014-05-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TH Management | Management | 2013 | — | — |
LM Management | Management | 2020 | — | — |
TH Chief Executive Officer | Chief Executive Officer | 2013 | — | — |
LM Management | Management | 2017 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
OSKAR H. HOLDING ApS | Company | 100.0% | 100.0% | 2013 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
OSKAR H. HOLDING ApS
LIFECORE BIOLOGY ApS Board members of LIFECORE BIOLOGY ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Trine Henriksen | Management | 0 companies |
| Laura Michelle Hartelius | Management | 0 companies |
| Tore Hartelius | Chief Executive Officer | 0 companies |
| Laura Michelle Owen | Management | 0 companies |